Eloxx Pharma (ELOX) Stock Price, Quote, News & History | Benzinga

SPY767.57+0.14%QQQ717.47−0.12%BTC/USD—DIA520.90+0.38%GLD377.99−0.45%TLT79.72+0.33%

Eloxx Pharmaceuticals Inc (ELOX) Stock Price, Quote, News & History

ELOXNASDAQ

Trade with Public

Trade with Public

$12.50

-0.53-4.07%

Last update: Oct 15, 7:57 AM

$12.50

-0.53-4.07%

OverviewNews Earnings Forecast Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

-

Close

$12.50

Volume / Avg.

0 / 44.04K

Day Range

- - -

52 Wk Range

0.00 - 23.40

Market Cap

$42.95M

P/E Ratio

3.55

Dividend Yield

-

Exchange

NASDAQ

RSI

33

Short Interest

1.77%

Days to Cover

2.42

Recent Eloxx Pharmaceuticals Inc News

This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Neutral on RDW, Overweight on ELOX, Buys on SGHT and AU, and Market Perform on FFIN.

Avi Kapoor

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.

Lisa Levin

Why US Steel Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) shares surged 49.4% to $1.31 in pre-market trading after the company reported a 325% year-over-year growth in its second-quarter revenue.

Lisa Levin

Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Lisa Levin

Why Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Gainers Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares surged 106.8% to $5.77 in pre-market trading. The stock began trading on a 1:18 reverse split on July 10.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-16.02M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

77.41M

Free Cash Flow (TTM)

-16.02M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

61.39M

Analyst Trends and Forecast

2

Jul

2

Aug

1

Sep

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$39.17M

PE Ratio (TTM)

3.55

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.93

Earnings Yield % (TTM)

28.16%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$13.51

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$600.00K

LT Debt Repayment (TTM)

$0

Total Cash

$61.96M

Debt to Equity

-

Issuance of Debt (TTM)

$600.00K

Repayment of Debt (TTM)

$0